{
  "event_id": "b36f1f00f1e3",
  "ticker": "AMGN",
  "company_name": "Amgen",
  "drug_name": "Tezspire",
  "result": "approved",
  "pdufa_date": "2025-10-17",
  "approval_type": {
    "status": "found",
    "value": "bla",
    "source": "websearch:NAVIGATOR trial, NEJM 2021",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.104548",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Severe asthma",
    "source": "websearch:NAVIGATOR trial, NEJM 2021",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.104550",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "tezepelumab-ekko",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Respiratory",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.448050",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "TSLP inhibitor",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.011152",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:NAVIGATOR trial, NEJM 2021",
    "confidence": 0.95,
    "evidence": [
      "NAVIGATOR trial, NEJM 2021"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.104535",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "<0.001",
    "source": "websearch:NAVIGATOR trial, NEJM 2021",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.104542",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "56% reduction in annualized asthma exacerbations (RR 0.44)",
    "source": "websearch:NAVIGATOR trial, NEJM 2021",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.104545",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": false,
    "source": "derived_from_first_submission",
    "confidence": 0.95,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": 0,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "p_value_numeric": 0.001,
  "nct_ids": [
    "NCT02528214",
    "NCT03347279"
  ],
  "phase3_study_names": [
    "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Severe Steroid Dependent Asthma",
    "A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents With Severe Uncontrolled Asthma (NAVIGATOR)"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "count": 1061,
    "type": "ACTUAL",
    "nct_id": "NCT03347279",
    "source": "clinicaltrials.gov",
    "fetched_at": "2026-01-10T17:24:43.942823"
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": false,
    "priority_review": true,
    "orphan_drug": false,
    "accelerated_approval": false
  },
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "date": null,
    "outcome": null,
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:34.860320",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['ROMANIA', 'BELGIUM', 'SPAIN', 'NETHERLANDS', 'UKRAINE']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-10T13:11:34.860360",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": true,
    "status": "found",
    "source": "suffix_pattern",
    "confidence": 0.85,
    "tier": 3,
    "evidence": [
      "suffix match: tezepelumab-ekko"
    ],
    "searched_sources": [
      "suffix_pattern"
    ],
    "last_searched": "2026-01-10T13:11:17.308174",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": "2014-01-27",
    "status": "found",
    "source": "fda.gov",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [
      "Thousand Oaks CA facility - drug/device combo violations (Prolia, Enbrel prefilled syringes)"
    ],
    "searched_sources": [
      "fda.gov"
    ],
    "last_searched": "2026-01-11T04:05:14.880581",
    "error": null,
    "note": null
  },
  "fda_483_date": {
    "value": "2023-05-01",
    "status": "found",
    "source": "redica.com",
    "confidence": 0.8,
    "tier": 3,
    "evidence": [
      "Facility: Thousand Oaks, CA",
      "Outcome: N/A"
    ],
    "searched_sources": [
      "redica.com"
    ],
    "last_searched": "2026-01-11T05:25:26.298322",
    "error": null,
    "facility": "Thousand Oaks, CA"
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:30:53.908950",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:30:53.085497",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -85,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.221725",
  "original_case_id": "a028c3a6dc75",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:17:29.265856",
  "enriched_at": "2026-01-11T17:32:57.889298",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.011174",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": false,
    "status": "confirmed_none",
    "source": "websearch_adcom",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:57.889286"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_applicable",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:57.889294"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "FDA grants Tezspire breakthrough therapy designation for COPD"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:14.706056",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Tezspire (tezepelumab-ekko) FDA Approval History - Drugs.com Review - Food and Drug Administration N"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:17.423319",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:23.997597",
    "search_status": "CONFIRMED_NONE"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Tezspire (tezepelumab-ekko) FDA Approval History - Drugs.com US FDA Approves Tezspire in CRSwNP - Lo"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:15.953873",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:29:30.558567",
    "search_status": "CONFIRMED_NONE"
  }
}